Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Izokibep in non-infectious uveitis
NCT05384249Phase 2Terminated
- Sponsor
- Acelyrin
- Start
- Aug 2022
- Primary completion
- Feb 2025
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 7
01
Overview
A Phase 2 trial of izokibep in non-infectious intermediate uveitis, Posterior uveitis (non-infectious), non-infectious panuveitis (NIU), sponsored by Acelyrin. Started Aug 2022; status: terminated.
02
Drugs
izokibep
03
Conditions
non-infectious intermediate uveitisPosterior uveitis (non-infectious)non-infectious panuveitis (NIU)
Beyond the preview
Go deeper on NCT05384249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05384249.